Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study.

Title: Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study. Authors: Kieran, Jennifer Ann; Norris, Suzanne; O'Leary, Aisling; Walsh, Cathal; Merriman, Raphael; Houlihan, D; McCormick, P Aiden; McKiernan, Susan; Bergin, Colm; Barry, Michael Abstract: Recent advances in Hepatitis C therapeutics offer the possibility of cure but will be expensive. The cost of treatment may be partially offset by the avoidance of advanced liver disease. We performed a micro-costing study of the ambulatory healthcare utilisation of patients with Hepatitis C supplemented with inpatient diagnosis related group costs.